Stop Schizophrenia Before It Starts? We Might Be on The Right Track
UCSF researcher Daniel Mathalon, MD, PhD, believes that burgeoning knowledge about biomarkers — biological measures of a medical condition that also serve as markers of treatment effectiveness — could help intercept schizophrenia.